Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 186-191

  Nakamura, Tomohiro ^a   Funayama, Hiroshi ^a   Kubo, Norifumi ^a   Yasu, Takanori ^a   Kawakami, Masanobu ^a   Momomura, Shin ichi ^a   Ishikawa, San e ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

BNP; Ischemic cardiomyopathy; Placental growth factor

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NORADRENALIN; PLACENTAL GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREGNANCY PROTEINS;

EID: 57549092937     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.10.050     Document Type: Article

References (23)

1. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
2. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel hormone in human. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
3. Espiner E.A., Richards A.M., Yandle T.G., and Nicholls M.G. Natriuretic hormones. Endocrinol Metab Clin N Am 24 (1995) 481-509
4. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with heart failure. Circulation 102 (2000) 3060-3067
5. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the VESnarinone Trial (VEST). Circulation 103 (2001) 2055-2059
6. Mattei M.G., Borg J.P., Rosnet O., Marme D., and Birnbaum D. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 32 (1996) 168-169
7. Autiero M., Luttun A., Tjwa M., and Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1 (2003) 1356-1370
8. Luttun A., Tjwa M., Moons L., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8 (2002) 831-840
9. Heeschen C., Dimmeler S., Fichtlscherer S., et al., for the CAPTURE Investigators. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 291 (2004) 435-441
10. Lenderink T., Heeschen C., Fichtlscherer S., et al., for the CAPTURE Investigators. Elevated placental growth factor levels are associated with adverse outcome at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 47 (2006) 307-311
11. Matsumori A., Furukawa Y., Hashimoto T., et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 221 (1996) 391-395
12. Hojo Y., Ikeda U., Zhu Y., et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 35 (2000) 968-973
13. Abraham D., Hofbauer R., Schafer R., et al. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res 87 (2000) 644-647
14. Taniyama Y., Morishita R., Aoki M., et al. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 40 (2002) 47-53
15. Li Y., Takemura G., Kosai K., et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 107 (2003) 2499-2506
16. Lamblin N., Susen S., Dagorn J., et al. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 150 (2005) 137-143
17. Chin B.S., Chung N.A., Gibbs C.R., Blann A.D., and Lip G.Y.H. Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol 90 (2002) 1258-1260
18. Green C.J., Lichtlen P., Huynh N.T., et al. Placental growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61 (2001) 2696-2703
19. Khaliq A., Dunk C., Jiang J., et al. Hypoxia downregulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 79 (1999) 151-170
20. Cao Y., Linden P., Shima D., Browne F., and Folkman J. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest 98 (1996) 2507-2511
21. Hattori K., Heissig B., Wu Y., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR 1(+) stem cell from bone-marrow microenvironment. Nat Med 8 (2002) 841-849
22. Iwama H., Uemura S., Naya N., et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 47 (2006) 1559-1567
23. Lamblin N., Mouquet M., Hennache B., et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J 26 (2005) 2245-2250